(ii) Deterioration of pre-existing diabetes or prediabetes without other attributable causes: Defined by an increase in fasting blood glucose by more than 50% compared to previous levels, necessitating the use of a second antihyperglycemic agent or insulin, or the occurrence of DKA, new-onset ketonuria, or ketonemia. The gene discussed is INS; the disease is diabetes mellitus.